American company at Durham in North Carolina, bought by BioIVT in 2017, which developed in vitro models of liver transporters. Provided the sandwich cultured hepatocyte based B-CLEAR system for measuring hepatobiliary transport and drug interactions, transporter certified hepatocytes and contract studies for pharmaceutical companies assessing drug clearance, transporter mediated interactions and drug induced liver injury for regulatory submissions.
Aucun commentaire disponible.
Laissez votre note & commentaire